Virtual CROI 2020: Highlights of Epidemiology, Public Health, and Prevention Research [0.03%]
虚拟CROI 2020：流行病学、公共卫生与预防研究重点摘要
Susan P Buchbinder,Albert Y Liu
Susan P Buchbinder
At the 2020 Conference on Retroviruses and Opportunistic Infections, held virtually as a result of the emerging COVID-19 pandemic, trends in the HIV epidemic were highlighted, with decreasing HIV incidence reported across several countries,...
Immune reconstruction inflammatory syndrome in HIV infection: beyond what meets the eye [0.03%]
人类免疫缺陷病毒感染中的免疫重建炎性综合征：不仅仅是眼见为实
Irini Sereti
Irini Sereti
A high proportion of individuals with HIV infection currently are diagnosed at an advanced stage of disease (late presenters), increasing their risk for immune reconstitution inflammatory syndrome (IRIS). IRIS typically occurs within 6 mont...
Judith A Aberg
Judith A Aberg
Effective antiretroviral therapy has extended life expectancy for individuals with HIV. Estimates from 2015 indicate that 47% of persons with HIV in the US were older than 50 years of age and 16% were older than 65 years. These older patien...
Magdalena E Sobieszczyk
Magdalena E Sobieszczyk
Therapeutic vaccines and broadly neutralizing antibodies (bNAbs) represent potential approaches to antiretroviral-free treatment of HIV. Although therapeutic vaccines have been able to produce transient reductions in viral load during analy...
Jonathan Li
Jonathan Li
Achieving a cure for HIV remains a priority in HIV research. Two cases of 'sterilizing cure' have been observed-in Timothy Ray Brown and the "London" patient; both patients received allogeneic hematopoietic stem cell transplantation (HSCT) ...
Annemarie M Wensing,Vincent Calvez,Francesca Ceccherini-Silberstein et al.
Annemarie M Wensing et al.
The 2019 edition of the IAS-USA drug resistance mutations list updates the Figure last published in January 2017. The mutations listed are those that have been identified by specific criteria for evidence and drugs described. The Figure is ...
HIV and the liver [0.03%]
HIV与肝脏
Kenneth E Sherman,Marion G Peters,David L Thomas
Kenneth E Sherman
Among individuals with HIV infection, liver disease remains an important cause of morbidity and mortality, even with the availability of agents that cure hepatitis C infection and suppress hepatitis B replication. The causes of liver diseas...
The Ryan White HIV/AIDS Program after the Patient Protection and Affordable Care Act full implementation: a critical review of predictions, evidence, and future directions [0.03%]
《病人保护与平价医疗法案》全面实施后莱安怀特艾滋病项目前景的批判性回顾：预测、证据和未来方向
Tamar Ginossar,John Oetzel,Lindsay Van Meter et al.
Tamar Ginossar et al.
The Ryan White HIV/AIDS Program (RWHAP) has been effective in serving people living with HIV (PLWH). Our goal was to examine the impact of the implementation of the Affordable Care Act (ACA) on the program's role in HIV care and its clients...
Michael S Saag
Michael S Saag
Antiretroviral therapy (ART) should be started as soon as possible after HIV diagnosis. Recommended starting ART regimens in patients with any baseline viral load include ictegravir plus tenofovir alafenamide (TAF)/emtricitabine (FTC), dolu...
Barbara S Taylor,Hong-Van Tieu,Joyce Jones et al.
Barbara S Taylor et al.
The 2019 Conference on Retroviruses and Opportunistic Infections included many exciting advances in antiretroviral therapy (ART). Investigators presented a case report of a second patient possibly cured of HIV through an allogeneic hematopo...